Resources with keywords: covid-19
Ventilation Improvement Strategies Among K–12 Public Schools — The National School COVID-19 Prevention Study, United States, February 14–March 27, 2022
CDC/MMWR
7 June 2022
Aerosol particle emission increases exponentially above moderate exercise intensity resulting in superemission during maximal exercise (NEW 6/2, Website, Publication)
Proceedings of the National Academy of Sciences of the USA
23 May 2022
Mutsch B, Heiber M, Grätz F, Hain R, Schönfelder M, Kaps S, Schranner D, Kähler CJ, Wackerhage H
SARS CoV 2 Laboratory Safety Guidance (NEW 6/2, Document, Regulatory)
African Society for Laboratory Medicine
Slide presentation on Laboratory Safety practices
COVID-19 Safe handling and processing for samples in laboratory (NEW 6/2, Website, Regulatory)
Public Health England
This PHE guidance has been produced in collaboration with the Health and Safety Executive and will be updated when new information becomes available.
Covid-19 vaccines and hearing loss and tinnitus (NEW 5/6, Website, News)
World Health Organization (WHO) - Pharmaceuticals Newsletter
29 April 2022
Rausch, C, et al
(No. 1, 2022) page 18
Seroprevalence of Infection-Induced SARS-CoV-2 Antibodies — United States, September 2021–February 2022 (NEW 5/6, Website, Publication)
CDC/MMWR
29 April 2022
Clarke KE, Jones JM, Deng Y, et al.
keywords: covid-19, seroprevalence
Incidence of Guillain-Barré Syndrome After COVID-19 Vaccination in the Vaccine Safety Datalink (Website, Publication)
JAMA Network
26 April 2022
Incidence of Guillain-Barré Syndrome After COVID-19 Vaccination in the Vaccine Safety Datalink. JAMA Netw Open. 2022;5(4):e228879. doi:10.1001/jamanetworkopen.2022.8879
Hanson KE, Goddard K, Lewis N, et al.
Surveillance data from the Vaccine Safety Datalink showed increased incidence rate of confirmed GBS 1 to 21 days after receiving the Ad.26.COV2.S (Janssen).
